Literature DB >> 8794792

Characterization of mucin in whole-gut lavage fluid obtained from patients with inflammatory bowel disease.

H Saitoh1, K Takagaki, T Nakamura, A Munakata, Y Yoshida, M Endo.   

Abstract

Whole-gut lavage fluid, collected by administering an electrolyte lavage solution orally, was found to be an excellent and easily collectable source of abundant mucin. Furthermore, the biochemical features of the mucin from patients with ulcerative colitis and Crohn's disease were investigated. The mucin was separated into four fractions by Sepharose CL-4B, Sepharose CL-2B, and DEAE Sephacel chromatography. Compared with healthy subjects, the total yields of mucin from ulcerative colitis patients were low due to a deficiency of neutral mucin, whereas those from Crohn's disease patients were high, which was attributable mainly to high-molecular-weight mucin. The fucose and sulfate contents were low in ulcerative colitis, but only the former was low in Crohn's disease. The different biochemical features of the mucin obtained from whole gut lavage fluid appear to reflect mucosal pathological changes associated with inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8794792     DOI: 10.1007/bf02088743

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  33 in total

1.  MUC-2 human small intestinal mucin gene structure. Repeated arrays and polymorphism.

Authors:  N W Toribara; J R Gum; P J Culhane; R E Lagace; J W Hicks; G M Petersen; Y S Kim
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

2.  Classification of inflammatory bowel disease.

Authors:  J E Lennard-Jones
Journal:  Scand J Gastroenterol Suppl       Date:  1989

3.  Mucin depletion in inflammatory bowel disease.

Authors:  D A McCormick; L W Horton; A S Mee
Journal:  J Clin Pathol       Date:  1990-02       Impact factor: 3.411

4.  In vitro mucus glycoprotein production by colonic tissue from patients with ulcerative colitis.

Authors:  G F Cope; R V Heatley; J Kelleher; A T Axon
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

5.  Human gastric mucin. Identification of a unique species by expression cloning.

Authors:  N W Toribara; A M Roberton; S B Ho; W L Kuo; E Gum; J W Hicks; J R Gum; J C Byrd; B Siddiki; Y S Kim
Journal:  J Biol Chem       Date:  1993-03-15       Impact factor: 5.157

6.  Microquantitative analysis of neutral and amino sugars as fluorescent pyridylamino derivatives by high-performance liquid chromatography.

Authors:  H Takemoto; S Hase; T Ikenaka
Journal:  Anal Biochem       Date:  1985-03       Impact factor: 3.365

7.  Diagnosis of colon cancer by lavage cytology with an orally administered balanced electrolyte solution.

Authors:  A S Rosman; Q Federman; L Feinman
Journal:  Am J Gastroenterol       Date:  1994-01       Impact factor: 10.864

8.  Ion exchange chromatography of purified colonic mucus glycoproteins in inflammatory bowel disease: absence of a selective subclass defect.

Authors:  A Raouf; N Parker; D Iddon; S Ryder; B Langdon-Brown; J D Milton; R Walker; J M Rhodes
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

9.  Mucosal glucosamine synthetase activity in inflammatory bowel disease.

Authors:  M C Winslet; V Poxon; A Allan; M R Keighley
Journal:  Dig Dis Sci       Date:  1994-03       Impact factor: 3.199

10.  The saccharides of the MUC 1 mucin-type glycoprotein, epitectin, produced by H.Ep.2 cells in the presence of aryl-N-acetyl-alpha-galactosaminides.

Authors:  N A DiIulio; V P Bhavanandan
Journal:  Glycobiology       Date:  1995-03       Impact factor: 4.313

View more
  3 in total

1.  Biotin and pantothenic acid oversupplementation to conditional SLC5A6 KO mice prevents the development of intestinal mucosal abnormalities and growth defects.

Authors:  Subrata Sabui; Rubina Kapadia; Abhisek Ghosal; Michael Schneider; Nils W G Lambrecht; Hamid M Said
Journal:  Am J Physiol Cell Physiol       Date:  2018-04-18       Impact factor: 4.249

2.  Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome.

Authors:  G Kristjánsson; P Venge; A Wanders; L Lööf; R Hällgren
Journal:  Gut       Date:  2004-12       Impact factor: 23.059

Review 3.  Therapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel Disease.

Authors:  Jing Sun; Xiao Shen; Yi Li; Zhen Guo; Weiming Zhu; Lugen Zuo; Jie Zhao; Lili Gu; Jianfeng Gong; Jieshou Li
Journal:  Nutrients       Date:  2016-01-14       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.